HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

AS1411-conjugated gold nanospheres and their potential for breast cancer therapy.

Abstract
AS1411 is a quadruplex-forming DNA oligonucleotide that functions as an aptamer to target nucleolin, a protein present on the surface of cancer cells. Clinical trials of AS1411 have indicated it is well tolerated with evidence of therapeutic activity, but improved pharmacology and potency may be required for optimal efficacy. In this report, we describe how conjugating AS1411 to 5 nm gold nanospheres influences its activities in vitro and in vivo. We find that the AS1411-linked gold nanospheres (AS1411-GNS) are stable in aqueous and serum-containing solutions. Compared to unconjugated AS1411 or GNS linked to control oligonucleotides, AS1411-GNS have superior cellular uptake and markedly increased antiproliferative/cytotoxic effects. Similar to AS1411, AS1411-GNS show selectivity for cancer cells compared to non-malignant cells. In a mouse model of breast cancer, systemic administration of AS1411-GNS could completely inhibit tumor growth with no signs of toxicity. These results suggest AS1411-GNS are promising candidates for clinical translation.
AuthorsMohammad T Malik, Martin G O'Toole, Lavona K Casson, Shelia D Thomas, Gina T Bardi, Elsa Merit Reyes-Reyes, Chin K Ng, Kyung A Kang, Paula J Bates
JournalOncotarget (Oncotarget) Vol. 6 Issue 26 Pg. 22270-81 (Sep 08 2015) ISSN: 1949-2553 [Electronic] United States
PMID26045302 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • AGRO 100
  • Aptamers, Nucleotide
  • Oligodeoxyribonucleotides
  • Gold
Topics
  • Animals
  • Aptamers, Nucleotide
  • Breast Neoplasms (genetics, therapy)
  • Cell Line, Tumor
  • Female
  • Gold (administration & dosage)
  • Humans
  • MCF-7 Cells
  • Metal Nanoparticles (administration & dosage)
  • Mice
  • Mice, Nude
  • Nanospheres (administration & dosage)
  • Oligodeoxyribonucleotides (administration & dosage)
  • Random Allocation
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: